<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Oral contraceptives and venous thromboembolism
2
Oral contraceptives and venous thromboembolism
3
Oral contraceptives and venous thromboembolism
4
Oral contraceptives and venous thromboembolism
5
Oral contraceptives and venous thromboembolism
6
Oral contraceptives and venous thromboembolism
7
Oral Contraceptives Can Cause Falsely Low Vitamin B12 Levels
8
Oral contraceptives do not raise risk of heart disease
9
Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers
10
Oral contraceptives, parity, and cervical cancer
11
Oral corrective feedback in the foreign language classroom: how it affects interaction in analytic foreign language teaching
12
Oral Corrective Feedback Preferences in Iranian L2 Learners with Different Proficiency Levels
13
Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis
14
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial Original Research Article
15
Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine
16
Oral cysticercosis
17
Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: randomized, double-blind, placebo-controlled study
18
Oral d,l-sotalol in atrial fibrillation and/or flutter
19
Oral decitabine reactivates fetal hemoglobin in baboons (Papio anubis)
20
Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV)
21
Oral delivery of G protein-coupled receptor modulators: An explanation for the observed class difference
22
Oral delivery of heparin: SNAC and related formulations
23
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
24
Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests
25
Oral delivery of live yeast Debaryomyces hansenii modulates the main innate immune parameters and the expression of immune-relevant genes in the gilthead seabream (Sparus aurata L.)
26
Oral delivery of proteins by biodegradable nanoparticles
27
Oral delivery of salmon calcitonin
28
Oral delivery of salmon calcitonin
29
Oral developmental toxicity study of methylsulfonylmethane in rats
30
Oral dexamethasone for the treatment of pain in children with acute pharyngitis: A randomized, double-blind, placebo-controlled trial
31
Oral Dexmedetomidine Versus Midazolam as Anesthetic Premedication in Children Undergoing Congenital Heart Surgery
32
ORAL DEXMEDETOMIDINE VERSUS ORAL MIDAZOLAM AS PREMEDICATION IN CHILDREN
33
Oral d-fenfluramine test in treatment-refractory depression: Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group
34
Oral Diagnostic Testing for Detecting Human Immunodeficiency Virus-1 Antibodies: A Technology Whose Time Has Come
35
Oral Diagnostics for the Geriatric Populations: Current Status and Future Prospects
36
Oral dietary supplements before and after surgery
37
Oral dietary supplements before and after surgery
38
Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial
39
Oral Diphenhydramine-Midazolam Versus Oral Diphenhydramine for Pediatric Sedation in the Emergency Department
40
Oral Direct Renin Inhibition: Premise, Promise, and Potential Limitations of a New Antihypertensive Drug
41
Oral Disease Burden in Patients Undergoing Prosthetic Heart Valve Implantation
42
Oral disorders: unapproved treatments or indications
43
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses
44
Oral doxycycline for neuroborreliosis
45
Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration
46
Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
47
Oral drug absorption enhancement by chitosan and its derivatives
48
Oral drug delivery systems using chemical conjugates or physical complexes
49
Oral drug delivery utilizing intestinal OATP transporters
50
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
51
Oral drug self-administration: an overview of laboratory animal studies
52
Oral ecosystem alterations in celiac children: A follow-up study
53
Oral Embryonal Rhabdomyosarcom in an Adult Addict Man: a case report and review of literature
54
Oral English Communication Difficulties and Coping Strategies of Diploma of Hotel Management Students at UiTM
55
Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions
56
Oral Erosive Lichen Planus Regression After Thymoma Resection
57
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: A phase II study with a 5-year follow-up
58
Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men Original Research Article
59
Oral etoposide and palliative treatment for small-cell lung cancer
60
Oral exposure of Kunming mice to diisononyl phthalate induces hepatic and renal tissue injury through the accumulation of ROS. Protective effect of melatonin
61
Oral exposure to the organophosphorus insecticide, Monocrotophos induces intestinal dysfunction in rats
62
Oral extended release of dexamethasone: Montmorillonite–PLGA nanocomposites as a delivery vehicle
63
Oral fecal parasites and personal hygiene of food handlers in Abeokuta, Nigeria
64
ORAL FEEDBACK IN CLASSROOM SLA A Meta-Analysis
65
Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation
66
Oral fennel (Foeniculum vulgare) drop effect on primary dysmenorrhea: Effectiveness of herbal drug
67
Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers
68
Oral Fibrolipoma: A Report of Two Cases
69
Oral Fibrolipoma-A Rare Histological Entity: Report of 3 Cases and Review of Literature
70
Oral fibrosis among teenagers chewing tobacco, areca nut, and Pan masala
71
Oral findings and health status among hospitalized patients with physical disabilities, aged 60 or above
72
Oral Findings and Salivary Parameters in Children with Celiac Disease: A Preliminary Study
73
Oral findings in children with celiac disease
74
Oral Findings in Newborn Children in and around Mangalore, Karnataka State, India
75
Oral Findings, Salivary Bicarbonate, and Phosphate Levels in Patients with Gastroesophageal Reflux Disease
76
Oral flecainide is not sensitive enough to rule out Brugada-Syndrome
77
Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection
78
Oral fluid collection by post—a pilot study of two approaches
79
Oral fluid proteolytic effects on histatin 5 structure and function
80
Oral Fluid Therapy for Treatment of Neonatal Diarrhoea in Calves
81
Oral fluid therapy in paediatric burns (5–10%): an appraisal
82
Oral Focal Mucinosis: A Case Report and Literature Review
83
Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
84
Oral fumarate for relapsing-remitting multiple sclerosis
85
Oral Functional Assessment Training in Speech Therapy Students using Virtual Reality (VR)
86
Oral functional outcome after intraoral reconstruction with nasolabial flaps
87
Oral fungal infections
88
Oral Gabapentin for the Treatment of Potoperative Pain after Photorefractive Keratectomy Original Reearch Article
89
Oral Gabapentin Treatment for ymptomatic Heimann-Bielchowky Phenomenon
90
Oral Gabapentin Versus Rectal Diclofenac for Postoperative Analgesia
91
Oral ganciclovir fails to prevent CMV in HIV trial
92
Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study
93
Oral glucocorticoids diminish the efficacy of allergen-specific immunotherapy in experimental feline asthma
94
Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: Implications for human efficacy and toxicity
95
Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E
96
Oral glucose retention, saliva viscosity and flow rate in 5-year-old children
97
Oral glucose supplementation improved semen quality and constituents of seminal and blood plasma of NZW buck rabbits in the subtropics
98
ORAL GLUCOSE TOLERANCE TEST (OGTT) IN NORMAL CONTROL AND GLUCOSE INDUCED HYPERGLYCEMIC RATS WITH COCCINIA CORDIFOLIA L. AND CATHARANTHUS ROSEUS L.
99
Oral glucose tolerance test and the preparatory diet,
100
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts
101
Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread
102
Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production
103
Oral glutamine: does it make sense?
104
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease
105
Oral glycoprotein IIb/IIIa inhibition—great idea, but it didn’t work
106
Oral Graft-Versus-Host Disease
107
Oral Graft-Versus-Host Disease
108
Oral Granular Cell Tumor: A Case Report with Emphasis on Pseudoepitheliomatous Hyperplasia in Oral Lesions
109
Oral Grapeseed Oil and Sesame Oil in Experimental Acetic Acid-Induced Ulcerative Colitis in Rat
110
Oral Hairy Leukoplakia: Clinical Indicator of an Immunosuppressive Condition and Challenges in Patient Management
111
Oral Health among 35- to 44-Year-Old Iranians
112
Oral health and bone mineral density in postmenopausal women
113
Oral Health and Coronary Artery Disease, A Review Article
114
Oral Health and Coronary Artery Disease, A Review Article
115
Oral Health and Dental Care During Pregnancy
116
Oral health and general health at the early stage of ageing: A review of contemporary studies
117
Oral health and linear growth in primary school children: a five-year longitudinal study
118
Oral Health and Oral Health Related Quality of Life among Elderly People in Iran
119
Oral Health and Pediatricians: Results of a National Survey
120
Oral Health and Quality of Life Among Elderly in Thailand
121
Oral health and quality of life in New Zealand: A social perspective
122
Oral Health and Related Quality of Life in Older People: A Sys-tematic Review and Meta-Analysis
123
ORAL HEALTH AND SALIVARY PROFILES OF GERIATRIC OUTPATIENTS IN CIPTO MANGUNKUSUMO GENERAL HOSPITAL
124
Oral health and school performance in elementary students: A cross-sectional study in a group of Iranian students, Tehran, Iran
125
Oral Health and Treatment Needs among 18-Year-Old Iranians
126
Oral Health Awareness and Practices of Special Needs Caregivers in Qatif, Saudi Arabia
127
Oral Health Awareness and Status among Universiti Kebangsaan Malaysia First Year Dental Students
128
Oral Health Behavior and Its Relationship with Quality of Life among 12 Year-old Children of Rafsanjan in 2017-18
129
Oral health behavior differences between dental students in graduate and doctoral programs
130
Oral Health Behaviors in a Sample of Portuguese Adolescents: An Educational Issue
131
Oral health behaviour and self-esteem in Swedish children
132
Oral Health Behaviours and Preventive Dental Care Experiences Among Patients with Special Health Care Needs at Special Care Dentistry Clinic, University of Malaya
133
Oral health behaviours in relation to caries and gingivitis in primary-school children in Tehran, 2008
134
Oral Health Burden in Children with Systemic Diseases
135
Oral Health Care Behavior in a Group of Turkish Children
136
Oral Health Care Education Regarding the Gingival Health, Knowledge, Attitude, and Behavior of the Pregnant Women
137
Oral Health Change in Iran: Part V; It Is the Time to Focus on MIH by an Electronic Approach - Letter to the Editor
138
Oral Health Characteristics and Dental Rehabilitation of Children with Global Developmental Delay
139
Oral Health Determinants among Opium Users in Kerman, Iran
140
Oral Health Disparities in Older Adults: Oral Bacteria, Inflammation, and Aspiration Pneumonia
141
Oral Health Disparities in the United States
142
Oral Health Disparity in Older Adults: Dental Decay and Tooth Loss
143
Oral health during pregnancy: A study from women with pregnancy
144
Oral health education program among pre-school children: an application of health-promoting schools approach
145
Oral Health Impact Profile and Associated Variables in Southern Brazilian Drug Users
146
Oral Health in Children: A Pediatric Health Priority
147
Oral health in long-term care: The implications of organizational culture
148
Oral health in pregnancy (Guidelines to gynaecologists, general physicians oral health care providers)
149
Oral Health In The Population Of Iasos (Byzantine Period)
150
Oral Health Indices in Patients With Type 2 Diabetes Receiving Insulin Treatment Compared With Metformin: A Cross-sectional Study
151
Oral Health Inequalities among and Within Neo‑Marxian Social Classes in South Korea: A Nationwide Cross‑sectional Study
152
Oral Health Information Being Delivered to Yazd Population in 2011
153
Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review
154
Oral Health Issues for Adolescent Athletes
155
Oral Health Knowledge and Attitudes of Community Health Workers in East Azerbaijan, Iran
156
Oral health knowledge and sources of information among male secondary school children in Riyadh
157
Oral health knowledge in parents of Saudi cerebral palsy children
158
Oral health Knowledge of Diabetic Patients before and after the Education Package
159
Oral health knowledge of health care workers in special children’s center
160
Oral health knowledge, attitude and behaviour among Saudi school students in Jeddah city
161
Oral health knowledge, attitude and practices among health professionals in King Fahad Medical City, Riyadh
162
Oral Health Knowledge, Attitude, and Practice among Nursing Students in the NorthEastern Part of Rajasthan, India
163
Oral health knowledge, attitude, and status and oral health index among midwifery students of Tehran University of Medical Sciences, Iran
164
Oral Health Knowledge, Attitude, Behavior, and Self-efficacy Among Healthcare Professionals: A Cross-sectional Study
165
Oral health knowledge, attitudes and practices of people with diabetes in South of Tehran, Iran
166
Oral health knowledge, behaviour and practices among school children in Qatar
167
Oral Health Literacy Among Carers of Special Needs Children in Kuala Terengganu, Malaysia
168
Oral Health Literacy and Behaviour of Health Sciences University Students
169
Oral Health Literacy and its Determinants in Young Couples
170
Oral Health Literacy and Oral Health Behavior among Adolescents in Babol 2019
171
Oral Health Literacy and Oral Health Behavior of Senior Medical and Pharmacy Students
172
Oral health literacy and oral health behaviors of disadvantaged women residing in the slum area of Zahedan, Iran: A cross-sectional study
173
Oral Health Literacy in Iran: Insights from a Cross-Sectional Study on the Adult Population
174
Oral health literacy status among adult population of Iran: A systematic review
175
Oral Health Literacy: The New Imperative to Better Oral Health
176
Oral Health of Children with Autism: The Influence of Parental Attitudes and Willingness in Providing Care
177
Oral Health of Down Syndrome Adults in Bosnia and Herzegovina
178
Oral Health of Drug Abusers: A Review of Health Effects and Care
179
Oral health of elderly occupants in residential homes
180
Oral Health of Fasting Muslims
181
Oral health of Iranian children in 2004: a national pathfinder survey of dental caries and treatment needs
182
Oral health of psychiatric patients: A cross-sectional comparision study
183
Oral Health Opinions and Practices of Pediatricians: Updated Results From a National Survey
184
Oral Health Policy Amicable for the South Asian Association for Regional Cooperation Nations
185
Oral Health Policy Development Since the Surgeon Generalʹs Report on Oral Health
186
Oral health problems and mortality
187
Oral Health Professionals Within State-Sponsored Medical Response Teams: The IMERT Perspective
188
Oral Health Profile in Iranian Armed Force: Focusing on Prevention Strategies
189
Oral health related quality of life among adults reffered to dental clinic of Babol faculty of dentistry in 2009-2011
190
Oral health related quality of life and decay-missing-filled teeth in children with attention deficit hyperactivity disorder
191
ORAL HEALTH RELATED QUALITY OF LIFE AND PERIODONTAL STATUS OF A SELECTED MALAYSIAN ADULT POPULATION: A PILOT STUDY
192
Oral Health Related Quality of Life in Diabetic Patients
193
Oral health related quality of life in Indonesian middle-aged and elderly women
194
Oral health related quality of life in patients with diabetes mellitus type 2 in the year 2012
195
Oral health related quality of life in patients with head and neck tumors undergoing chemo and radiotherapy
196
Oral Health Related Quality of Life of Patients Using Conventional Dentures versus Implant-Supported Overdentures
197
Oral Health Status and its Determinants among a Group of Iranian Employees
198
Oral health status and oral health behavior of substance abusers in Kerman city, Iran, in year 2016
199
Oral health status and oral hygiene behaviour of orphan children: A survey in support centers in Kerman City, Iran, in 2019
200
Oral Health Status and Related Factors among Adult Patients Referred to Public Health Centers (Kerman-Iran)
201
oral health status and related factors in children with visual impairment aged 7-11 years: a cross-sectional study
202
Oral Health Status and Salivary Properties Among Children Before and After Tonsillectomy
203
ORAL HEALTH STATUS AND TREATMENT NEEDS OF A SCREENED UNIVERSITY POPULATION IN PORT HARCOURT, RIVERS STATE
204
Oral Health Status and Treatment Needs of Visual Impairment in Phitsanuloke, Thailand
205
Oral health status in patients with epilepsy
206
Oral health status in preschool asthmatic children in Iran.
207
Oral Health Status in the Iranian Elderly: The Role of Nutrition Status and Health Literacy
208
Oral Health Status in the Pars Cohort Study
209
Oral Health Status in Three Long Term Care Units of Schizophrenic Patients in Chaharmahal-Bakhtiari Province, Iran
210
Oral Health Status of 12 and 15YearOld Students in Qatar: Findings From the National Oral Health Survey
211
Oral health status of 12-year-old male schoolchildren in Medina, Saudi Arabia
212
Oral health status of a sample of disabled population in Iran
213
Oral Health Status of Children with Autistic Spectrum Disorder Compared with Non-authentic Peers
214
Oral Health Status of Children with Disability Living in Albania
215
Oral health status of disabled children
216
Oral Health Status of Low Birth Weight and Preterm Children
217
Oral health status of male adolescent smokeless tobacco users in Saudi Arabia
218
Oral Health Status of Patients Visiting Islamic International Dental Hospital
219
Oral health status of school children in Mbarara, Uganda
220
Oral health status of southern Chinese following head and neck irradiation therapy for nasopharyngeal carcinoma
221
Oral Health Status of the Professional Soccer Players in Thailand
222
Oral health status, dental needs, habits and behavioral attitude towards dental treatment of a groupof autistic children in Riyadh, Saudi Arabia
223
Oral health status, knowledge, attitude and practice of patients with heart disease
224
Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD
225
Oral health status, salivary pH status, and Streptococcus mutans counts in dental plaques and saliva of children with acute lymphoblastic leukemia
226
Oral health status, self‑perceived dental needs, and barriers to utilization of dental services among people with psychiatric disorders reporting to a tertiary care center in Haryana
227
Oral health, sociodemographic factors, dietary and oral hygiene practices in Jordanian children
228
Oral Health-Related Factors based on Health Belief Model in 10th to 12th-Grade Students in Kashan
229
Oral Health-Related Quality of Life among Parents and Teachers of Disabled Schoolchildren in Kuwait
230
Oral Health-Related Quality of Life Changes Following Third Molar Surgery in a Jordanian Population: Effect of Demographic and Clinical Factors on the Immediate Postoperative Period
231
Oral Health‑related Quality of Life in Older People in Kashan/Iran 2015
232
Oral Health-Related Quality of Life in Temporomandibular Disorder Patients Treated with Stabilization Splint
233
Oral health-related quality of life: a broader perspective
234
Oral Health-Related Quality of Life: A Cross-Sectional Survey among Adult Patients in Mashhad, Iran
235
Oral Hemorrhage in a 3-year-old Boy Caused by Self-Mutilating Behavior
236
Oral herbal supplement containing magnesium sulfate improve metabolic control and insulin resistance in non-diabetic overweight patients: A randomized double blind clinical trial
237
Oral herpetic infections (HSV 1–8)
238
Oral Histoplasmosis: Report of Two Cases
239
Oral Hobnail Hemangioma: A Case Report
240
Oral hygiene assessment by school teachers and peer leaders using simplified method
241
Oral hygiene awareness among female Saudi school children
242
Oral hygiene awareness among female Saudi school children
243
Oral Hygiene Behaviour Change in Dentistry Students During Dental Education
244
Oral hygiene evaluation for effective oral care in preventing pneumonia in dentate elderly
245
Oral Hygiene Evaluation Of The Patients Before Orthodontic Treatment
246
ORAL HYGIENE HABITS AND ORAL HEALTH STATUS OF FEMALE ADOLESCENTS UNDER STATE PROTECTION: A PILOT STUDY
247
Oral Hygiene Practices and Bottle Feeding Pattern Among Children with Early Childhood Caries: A Preliminary Study
248
Oral hygiene practices and dietary habits among children with Down’s Syndrome in Riyadh, Saudi Arabia
249
Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients
250
Oral Hygiene Status in a General Population of Iran, 2011: A Key Lifestyle Marker in Relation to Common Risk Factors of Non-Communicable Diseases
251
Oral hygiene status of Kuwaiti schoolchildren
252
Oral hypoglycemic agents in coronary artery bypass grafting
253
Oral hypoglycemics sold as valium on the streets: A case report
254
Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis
255
Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens
256
Oral Ibuprofen for Closure of Hemodynamically Significant Patent Dultus Arteriosus in Premature Neonates: a Pilot Study
257
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
258
Oral imipramine and intravenous xylazine for pharmacologically-induced ex copula ejaculation in stallions
259
Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms
260
Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms
261
Oral immunization induces local and distant mucosal immunity in swine
262
Oral immunization induces local and distant mucosal immunity in swine
263
Oral immunization of olive flounder (Paralichthys olivaceus) with recombinant live viral hemorrhagic septicemia virus (VHSV) induces protection against VHSV infection
264
Oral immunization of rainbow trout to infectious pancreatic necrosis virus (Ipnv) induces different immune gene expression profiles in head kidney and pyloric ceca
265
Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX
266
Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX
267
Oral Immunization with Enterocoated Microbeads Induces Antigen-Specific Cytolytic T-Cell Responses
268
Oral immunotherapy for food allergy: Clinical and preclinical studies
269
Oral Immunotherapy in Children: Ige-Dependent Food Allergy to Milk or Wheat
270
Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report
271
Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report
272
Oral impact on daily performance in Iranian adults
273
Oral Implications of Polypharmacy in the Elderly
274
Oral infection with human papillomavirus 16 common in children
275
Oral Infections and Glycemic Control in Pregnant Type 2 Diabetics
276
Oral infections and systemic diseases
277
Oral infiltrating lipomas
278
Oral ingestion of lidocaine for suicide: A case report
279
Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: Issues and opportunities, ,
280
Oral inoculation of Enterococcus faecalis, DNA quantification and histopathological evaluation of gingival, heart and kidney tissue samples in rats
281
Oral inoculation with Gymnorhynchus gigas induces anti-parasite anapyhylactic antibody production in both mice and rats and adverse reactions in challenge mice
282
Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial
283
Oral insulin delivery by self-assembled chitosan nanoparticles: In vitro and in vivo studies in diabetic animal model
284
Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination
285
Oral Intake of Semi-refined Carrageenan by Rats Affects Apoptosis of Lymphocytes
286
Oral intravascular papillary endothelial hyperplasia: a case report
287
Oral involvement in autoimmune blistering diseases
288
Oral iron chelators – development and application
289
Oral Iron Therapy with Polysaccharide-Iron Complex May be Useful in Increasing the Ferritin Level for a Short Time in Patients with Dilated Cardiomyopathy
290
Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study
291
Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue
292
Oral Ketamine or Nasal Midazolam for Sedation in Pediatric Upper Gastrointestinal Endoscopy
293
Oral ketoprofen is effective in the treatment of non-infectious lameness in sows
294
Oral l -arginine prevents murine coxsackievirus B3 myocarditis
295
Oral laquinimod for treatment of relapsing-remitting multiple sclerosis
296
Oral L-arginine (and other active ingredients) for ischemic heart disease?
297
Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial
298
Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men
299
Oral l-arginine supplementation impacts several reproductive parameters during the postpartum period in mares
300
Oral Lesion Description: A Mini Review
301
Oral Lesions among Women Living with or at Risk for HIV Infection
302
Oral Lesions Associated with Human Immunodeficiency Virus Disease
303
Oral Lesions in Kidney Transplant Patients
304
Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series
305
Oral lesions in Saudi renal transplant patients
306
Oral lesions of 500 habitual psychoactive substance users in Chennai, India
307
Oral leukoplakia: Diagnosis and treatment
308
Oral leukoplakia: Transmission electron microscopic correlation with clinical types and light microscopy
309
Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
310
Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial
311
Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure
312
Oral lichen planus
313
Oral Lichen Planus and Celiac Disease: is there any Relationship?
314
Oral Lichen Planus and Lichenoid Mucositis
315
Oral lichen planus and the burning mouth syndrome. Is there a role for patch testing?
316
Oral lichen planus in a child in association with psychological stress: A case report
317
Oral Lichen Planus in a Pediatric Patient: A Novel Therapeutic Approach
318
Oral Lichen Planus or Oral Lichenoid Reaction? A Literature Review
319
Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study
320
Oral lichen planus: a review
321
Oral Lichen Planus: Clinical Features, Etiology, Treatment and Management; A Review of Literature
322
Oral Lichen Planus: Diagnosis and Management
323
Oral lichen planus: Focus on etiopathogenesis
324
Oral Lichen Planus: Treatment of a Refractory Case (Case Report)
325
Oral Lichenoid Reaction: An Uncommon Side Effect of Rituximab
326
Oral lipid-based formulations
327
Oral Lipoma in Elderly Saudi Patient: A Case Report
328
ORAL LIPOMA: CASE REPORT
329
Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation
330
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study
331
Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
332
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study
333
Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study
334
Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study
335
Oral Magnesium Supplementation Decreases C-reactive Protein Levels in Subjects with Prediabetes and Hypomagnesemia: A Clinical Randomized Double-blind Placebo-controlled Trial
336
Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial
337
Oral magnesium supplementation in insulin-requiring patients with type 2 diabetes mellitus
338
Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease
339
Oral Magnesium; Migraine Prophylaxis
340
Oral malignant melanoma: A case report of an unusual clinical and histologic presentation
341
Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation
342
Oral Malodor-A Menace To Periodontist
343
Oral malodorous compounds are periodontally pathogenic and carcinogenic
344
Oral management of patients following oncology treatment: literature review
345
Oral manganese intake estimated with dietary records and with direct chemical analysis
346
Oral Manifestation and Caries Experience in Pre-Dialysis Chronic Kidney Disease Patient
347
Oral Manifestation and Dental Management of CATCH 22 Syndrome
348
Oral Manifestation and Presence of Candida albicans in Multiple Sclerosis Disease with Different Treatment Modalities
349
Oral Manifestation Associated with Biochemical and Hematological Changes in Iraqi End-Stage Renal Failure Patients
350
Oral Manifestations and Complications of Diabetes Mellitus
351
Oral Manifestations and Dental Management Considerations of Lipoid Proteinosis: A Case Report and Review of Literature
352
Oral Manifestations and Its Associated Factors in Iranian Systemic Lupus Erythematosus (SLE) Patients
353
ORAL MANIFESTATIONS AND PROSTHETIC REHABILITATION IN HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY (HSAN)TYPE IV: A CASE REPORT
354
Oral manifestations and related factors of HIV positive patients in south-east of Iran
355
Oral manifestations and related factors of HIV positive patients in south-east of Iran
356
Oral manifestations associated with human immunodeficiency virus infection in 200 Indian patients.
357
Oral Manifestations in COVID-19: a Missed Diagnostic Clue or a Mispresented Secondary Complication
358
Oral manifestations in inflammatory bowel disease: A cross‑sectional study in Isfahan
359
Oral manifestations in liver transplant recipients
360
Oral Manifestations in Obesity and Bariatric Surgery: Narrative Review
361
Oral Manifestations in Patients with Psoriasis: A Cross-Sectional Study
362
Oral manifestations in transplant patients
363
Oral manifestations of allograft recipients before and after renal transplantation
364
Oral Manifestations of Aplastic Anemia: A Case Report
365
Oral manifestations of drug therapy
366
Oral Manifestations of Ehlers-Danlos Syndrome and Presentation of a Case
367
Oral manifestations of HIV disease
368
Oral manifestations of HIV infection
369
Oral Manifestations of Human Immunodeficiency Virus-Infected Patients
370
Oral Manifestations of Internal Malignancy and Paraneoplastic Syndromes
371
Oral manifestations of lamellar ichthyosis: A rare case report and review
372
Oral Manifestations of Patients Taking Anti-Hypertensive Medications
373
Oral manifestations of patients with lupus erythematosus
374
Oral manifestations of sexually transmitted diseases
375
Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70)
376
Oral Manifestations Related To CD4 Lymphocyte Count in HIV-Positive Patients
377
Oral Manifestations With Tissue Alterations of Nas or Pan Consumption: A Case Study in Bandar Abbas (Iran) in 2018
378
Oral mature teratoma containing epididymal tissue in a female neonate
379
Oral melanoma with pulmonary metastasis in a Nigerian local dog
380
ORAL MELANOSIS: A CASE SERIES
381
Oral Melatonin for Colistin-induced Nephrotoxicity Reduction in Intensive Care Unit: A Randomized Placebo Controlled Clinical Trial
382
Oral melatonin in neurologically disabled children
383
Oral melatonin in neurologically disabled children
384
Oral melatonin in neurologically disabled children
385
Oral Melatonin Versus Midazolam as Premedication for Intravenous Sedation in Pediatric Dental Patients
386
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
387
Oral metastases: report of 24 cases
388
Oral Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report
389
Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion,
390
Oral methotrexate for treatment of ectopic pregnancy
391
Oral Methylated N-Aryl Chitosan Derivatives for Inducing Immune Responses to Ovalbumin
392
ORAL MICROBES AND ITS ENVIRONMENT: A REVIEW ARTICLE
393
Oral microbial colonization in children with sickle cell anaemia under long-term prophylaxis with penicillin
394
Oral Microbiome in Head and Neck Cancers: An Insight, Are We Looking at a Step Beyond in Unraveling the Challenge?
395
Oral Microflora in Patients on Hemodialysis and Kidney Transplant Recipients
396
Oral microflora of stray domestic cats (Felis catus) found in the premises of two human hospitals in Sokoto, Nigeria
397
Oral Midazolam and Emergence Delirium
398
Oral Midazolam for Voiding Dysfunction in Children Undergoing Voiding Cystourethrography: A Controlled Randomized Clinical Trial
399
Oral Midazolam Vs Promethazine as Pre Sedation Medication in Pediatric Dentistry
400
Oral Midazolam-Ketamine versus Midazolam alone for Procedural Sedation of Children Undergoing Computed Tomography; a Randomized Clinical Tri-al
401
Oral misoprostol for postpartum haemorrhage
402
Oral misoprostol for premature rupture of membranes at term
403
Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial
404
Oral misoprostol or vaginal dinoprostone for labor induction: A randomized controlled trial
405
Oral misoprostol versus oxytocin in the management of third stage of labour
406
Oral morphine consumption reduces lens development in rat embryos
407
Oral morphology and dietary choices of goats on rangeland
408
Oral motor patterns during feeding in severely physically disabled children
409
Oral mucoceles: A clinical, histopathological and immunohistochemical study
410
Oral mucosa and Streptococcus mutans count in the saliva. Does graphene oxide nanoparticle mouthwash have a good effect?
411
Oral mucosa grafts for urethral reconstruction
412
Oral mucosa lesions and risk habits: a cross-sectional study in North Serbia student population
413
ORAL MUCOSA MYIASIS CAUSED BY OESTRUS OVIS
414
Oral mucosal embryology and histology
415
Oral Mucosal Lesions and Adverse Habits Among Hospitalized Tuberculosis Patients of Udaipur, Rajasthan, India
416
Oral mucosal lesions and developmental anomalies in dental patients of a teaching hospital in Northern Taiwan
417
Oral mucosal lesions and risk factors in elderly dental patients
418
Oral mucosal lesions in complete denture wearers
419
Oral mucosal lesions: a retrospective review of one institution’s 13-year experience
420
Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome
421
Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area
422
Oral mucosal wetness in hypo- and normosalivators
423
Oral mucositis
424
Oral mucositis in patients with leukaemia following high-dose chemotherapy and autologous haematopoietic stem cells transplantation
425
Oral Mucositis Prevention and Management by Therapeutic Laser in Head and Neck Cancers
426
Oral Mucous Membrane Pemphigoid With Positive Nikolsky’s Sign: A Case Report
427
Oral multiple sclerosis treatment gains support
428
Oral Myiasis Affecting Gingiva in a Child Patient: An Uncommon Case Report
429
Oral myiasis by screwworm Cochliomyia hominivorax
430
Oral Myiasis: A Rare Case Report and Literature Review
431
Oral Narratives by Hearing-Impaired Students in Ordinary Schools- A SFG Study
432
Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor
433
Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study
434
Oral nodular fasciitis: case report
435
Oral Oncoprevention by Phytochemicals - A Systematic Review Disclosing the Therapeutic Dilemma
436
Oral Opportunistic Bacteria in Multiple Sclerosis with Different Treatment Modalities
437
Oral or intravenous methylprednisolone for acute relapses of MS?
438
Oral or Intravenous N-Acetylcysteine for Acetaminophen Poisoning?
439
Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia
440
Oral or parenteral therapy for B12 deficiency
441
Oral or parenteral therapy for vitamin B12 deficiency
442
Oral or parenteral therapy for vitamin B12 deficiency
443
Oral or parenteral therapy for vitamin B12 deficiency
444
Oral or rectal diclofenac for laparoscopic sterilization
445
Oral or topical administration of L-arginine changes the expression of TGF and iNOS and results in early wounds healing
446
Oral ornithine a-ketoglutarate accelerates healing of thesmall intestine and reduces bacterial translocation after abdominal radiation
447
Oral Oxycodone Compared With Intravenous Morphine Sulfate for Pain Management of Isolated Limb Trauma; a Randomized Clinical Trial
448
Oral Papillomatosis in a Dog: Surgical Management and Histopathological Findings
449
Oral Paraneoplastic Pemphigus and Pharyngeal Squamous Cell Carcinoma: A Rare Case Report and Review of Literature
450
Oral pathology – Pertinent papers published in 2002–2003: A personal view
451
Oral pathology – Pertinent papers published in 2004: A personal view
452
Oral pemphigoid autoantibodies preferentially target BP180 ectodomain
453
Oral peptide drug delivery: polymer–inhibitor conjugates protecting insulin from enzymatic degradation in vitro
454
ORAL PERFORMANCE AS SIREN The Example of Ozoemena Nwa Nsugbe
455
Oral pH and drinking habit during ingestion of a carbonated drink in a group of adolescents with dental erosion
456
Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency
457
Oral physostigmine in alzheimerʹs disease: Effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma
458
Oral pigmented lesions
459
Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial
460
Oral pleasure and expatriate satisfaction: an empirical approach
461
Oral poliomyelitis vaccines
462
Oral Potentially Malignant Disorders: An Overview of More than 20 Entities
463
Oral prednisolone for viral wheeze in young children
464
Oral prednisolone for viral wheeze in young children
465
Oral prednisolone in the treatment of cervical radiculopathy: A randomized placebo controlled trial
466
Oral premalignancies and squamous cell carcinoma
467
Oral Premedication for Pediatric Cardiac Surgery: A Comparison of Midazolam, Ketamine and Midazolam plus Ketamine
468
Oral premedication in patients with a history suggesting hypersensitivity to iodinated contrast media
469
Oral Presentation Versus Role Playing in Medical Education: A Quasi-Experimental Study
470
Oral Presentation vs. Free Discussion: Iranian Intermediate EFL Learners’ Speaking Proficiency and Perception
471
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans
472
ORAL PROBIOTIK: PENDEKATAN BARU TERAPI HALITOSIS (Tinjauan Pustaka)
473
Oral Problems and Psychological Status of Older Adults Referred to Hospital and Its Relationship With Cognition Status, Stress, Anxiety, and Depression
474
Oral processing characteristics of solid meal components, and relations with food composition, sensory attributes & expected-satiation
475
Oral processing characteristics of solid savoury meal components, and relationship with food composition, sensory attributes and expected satiation
476
Oral processing, texture and mouthfeel: From rheology to tribology and beyond
477
Oral Propranolol for Treatment of Pediatric Capillary Hemangiomas
478
Oral propranolol premedication and hypotensive anesthesia in shoulder arthroscopic surgery: a randomized controlled double-blind study
479
Oral propranolol versus cryotherapy in the management of cutaneous hemangioma in infants and children
480
Oral Psyllium Herbal Laxative , Clinical Trial in a Difficult Group
481
Oral Pulse Granuloma- A Rare Entity
482
Oral Pushed Output: the Route to Longterm Grammatical Accuracy
483
Oral pyogenic granuloma: a review of 38 cases from Ibadan, Nigeria
484
Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial
485
Oral Question Approach In Teaching By Malay Language Teachers: Observation Methode
486
Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis: The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study Original Research Article
487
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study Original Research Article
488
Oral rapamycin to prevent human coronary stent restenosis: A pilot study
489
Oral recombinant bovine somatotropin improves growth performance in rainbow trout (Oncorhynchus mykiss)
490
Oral Recombinant Mycobacterium bovis Bacillus Calmette–Guérin Expressing HIV-1 Antigens as a Freeze-Dried Vaccine Induces Long-Term, HIV-Specific Mucosal and Systemic Immunity
491
Oral Reconstruction of Hemi-Mandibulectomy Patients by Implant Overdenture: Report of Two Cases
492
Oral reconstruction using the peroneal flap
493
Oral Reference Dose for ethylene glycol based on oxalate crystal-induced renal tubule degeneration as the critical effect
494
Oral rehabilitation after radiotherapy; a review on prosthetic treatment options
495
Oral Rehabilitation and Management for Secondary Sjögren’s Syndrome in a Child
496
Oral rehabilitation by semi‑adjustable articulator
497
Oral Rehabilitation in Irradiated Patients: Implant- or Tooth-Supported Fixed Prosthesis? A Clinical Report
498
Oral Rehabilitation of a Patient with Papillon Lefèvre Syndrome Using Fixed Full-Arch Hybrid Prostheses Supported by Four Axially Loaded Implants: A Case Report with Four-Year Follow-up
499
Oral rehabilitation of amelogenesis imperfecta by complete overdentures: Case Report
500
Oral Rehabilitation of an Osteopetrosis Patient with Osteomyelitis
501
Oral Rehabilitation Using the Lip Muscle Trainer: A Narrative Review
502
Oral rehydration and hyponatraemia
503
Oral rehydration solution as adjuvant for oral vaccination
504
Oral rehydration solutions
505
Oral rehydration solutions for diabetics with acute diarrhoea
506
Oral rehydration therapy
507
Oral rehydration therapy improved for cholera
508
Oral renin inhibitors
509
Oral Requests in Advanced Level English Coursebooks and English Movies: An Evaluative Study
510
Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies
511
Oral retinoids pose no threat to back bones
512
Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials Review Article
513
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis
514
Oral Schwannoma: A Systematic Review of the Case Reports
515
Oral Schwannoma: A Systematic Review of the Case Reports
516
Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms
517
Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms
518
Oral Selenium: Can It Prevent Contrast-Induced Nephropathy Following Coronary Angiography and Angioplasty
519
Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation
520
Oral Self-Injurious Behaviors in Patients with Developmental Disabilities
521
Oral sensation of ethanol in a primate model III: responses in the lingual branch of the trigeminal nerve of Macaca mulatta
522
Oral sensations associated with the flavan-3-ols (+)catechin and (-)-epicatechin
523
Oral sensorimotor function for feeding in patients with tetanus
524
Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa
525
Oral Sildenafil After Bidirectional Cavopulmonary Shunt
526
Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt
527
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
528
Oral sildenafil in erectile dysfunction
529
Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment
530
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
531
Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension
532
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
533
Oral single pulse exposure of flounder Platichthys flesus to 4-tert-octylphenol: Relations between tissue levels and estrogenic effects
534
Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)
535
Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)
536
Oral Smokeless Tobacco Use with Special Reference to India
537
ORAL SNUFF AND CARCINOMA OESOPHAGUS
538
Oral Sodium Thiosulfate Solution as a Secondary Preventive Treatment for Calciphylaxis in Dialysis Patients
539
Oral solitary fibrous tumor: a cytogenetic analysis of tumor cells in culture with literature review
540
Oral species of Fusobacterium from human and environmental samples
541
Oral splint for temporomandibular joint disorders with revolutionary fluid system
542
Oral squamous cell cancer protein-protein interaction network interpretation in comparison to esophageal adenocarcinoma
543
Oral Squamous Cell Carcinoma and the Cutting Edge of Nanotechnology
544
Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms
545
Oral Squamous Cell Carcinoma with an Unusual Clinical Manifestation: A Case Report
546
ORAL SQUAMOUS CELL CARCINOMA WITH PSEUDO-GLANDULAR DIFFERENTIATION
547
Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening
548
Oral squamous cell carcinoma: Like owner, like cat
549
Oral statins and increased bone-mineral density in postmenopausal women Original Research Article
550
Oral status and nutrition in the institutionalized elderly
551
Oral Stereognosis in Children With Cleft Palate and Normal Children
552
Oral steroids as a cause of diverticulum perforation
553
Oral sterol intake in The Netherlands: evaluation of the results obtained by GC analysis of duplicate 24-h diet samples collected in 1994
554
Oral Story as Source for Tourism: A Comparative between Malaysia and Singapore
555
Oral Storytelling as an Act of Resistance in Morrison’s Tar Baby
556
Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs
557
Oral subchronic and genotoxicity studies conducted with the amino acid, l-glutamine
558
Oral submucous fibrosis and copper
559
Oral Submucous Fibrosis in a 15-year-old Boy: The First Case Report in Iran
560
Oral Submucous Fibrosis: a case report
561
Oral Submucous Fibrosis: A Chronic Deliberating Disease of Oral Cavity
562
Oral Substitution of Melatonin in Critical Care: A Pharmacokinetic Study in Patients with Intracranial Hemorrhage
563
Oral substitution treatments for opioid dependence
564
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
565
Oral Supplementation of B-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat
566
Oral Supplementation of β-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat
567
Oral supplements as adjunctive treatment to nutritionalcounseling in malnourished HIV infected patients: randomized controlled trial
568
Oral supplements differing in fat and carbohydrate content: effect on the appetite and food intake of undernourished elderly patients
569
Oral Surgery for Patients on Anticoagulant Therapy: Current Thoughts on Patient Management
570
ORAL SUSTAINED RELEASE PELLETS OF DILTIAZEM HCL WITH KOLLICOAT SR30
571
Oral Syphilis: A Reemerging Infection Prompting Clinicians’ Alertness
572
Oral Taurine Supplementation Modulates Ethanol-Conditioned Stimulus Preference
573
Oral Teratogenicity Studies of Methyl Bromide in Rats and Rabbits
574
Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial
575
Oral terbutaline in the outpatient management of preterm labor
576
Oral testosterone supplementation and chronic low-grade inflammation in elderly men: A 26-week randomized, placebo-controlled trial
577
Oral Theophylline Changes Renal Carnitine Palmitoyltransferase Activity in Rats
578
Oral therapeutics and oral cosmetics
579
Oral Therapy in a Diabetic Patient With History of Infantile Hyperinsulinism
580
Oral Thioctic Acid (a-Lipoic Acid) and Gabapentin as Co-adjuvants in Paraneoplastic Neuropathic Pain
581
Oral tolerance and autoimmune diabetes—will hope triumph over experience?
582
Oral tolerance and OVA-induced tolerogenic dendritic cells reduce the severity of collagen/ovalbumin-induced arthritis in mice
583
Oral tolerance correlates with high levels of lymphocyte activity
584
Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-inducedand high-fat-diet-driven atherosclerotic lesions
585
Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells
586
Oral tolerance: Mechanisms and possible role in inflammatory joint diseases
587
Oral Tolerance: New Approaches, New Problems
588
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial
589
Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats
590
Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats
591
Oral Toxicity and Carcinogenicity Studies of Sucrose Acetate Isobutyrate (SAIB) in the Fischer 344 Rat and B6C3F1 Mouse
592
ORAL TOXICITY AND REPELLENT EFFECT OF SOME INSECTICIDES AGAINST HONEYBEE WORKERS
593
Oral toxicity evaluation of kefir-isolated Lactobacillus kefiranofaciens M1 in Sprague–Dawley rats
594
Oral toxicity of a tocotrienol preparation in rats
595
Oral Toxicity of Bis(2-Ethylhexyl) Phthalate During Pregnancy and Suckling in the Long–Evans Rat
596
Oral Toxicity of Thymol, α-Pinene, Diallyl Disulfide and Trans-Anethole, and Their Binary Mixtures against Tribolium castaneum Herbst Larvae (Coleoptera: Tenebrionidae)
597
Oral toxicological studies of black soybean (Glycine max) hull extract: Acute studies in rats and mice, and chronic studies in mice
598
Oral Tradition and Identity of West Kalimantan Society
599
Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study
600
Oral transmission of BSE to primates
601
Oral transmucosal drug delivery for pediatric use
602
Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study
603
Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study
604
Oral treatment options for degenerative joint disease—presence and future
605
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
606
Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease
607
Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity
608
Oral ulcerations due to drug medications
609
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study
610
Oral vaccination of African catfish with Vibrio anguillarum O2: effect on antigen uptake and immune response by absorption enhancers in lag time coated pellets
611
Oral vaccination of BacFish-vp6 against grass carp reovirus evoking antibody response in grass carp
612
Oral vaccination of dogs with recombinant rabies virus vaccines
613
Oral vaccination of fish againstVibrio anguillarumusing alginate microparticles
614
Oral vaccination of juvenile carp (Cyprinus carpio) and gilthead seabream (Sparus aurata) with bioencapsulatedVibrio anguillarumbacterin
615
Oral vaccines against cholera: lessons from Vietnam and elsewhere
616
Oral Verruciform Xanthoma within Lichen Planus: A Case Report and Literature Review
617
Oral Verrucous Carcinoma and Ameloblastoma: A Rare Coincidence
618
Oral Versus Intramuscular Ondansetron for Reducing Vomiting in Children with Acute Gastroenteritis: A Single-Blind Randomized Clinical Trial
619
Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study
620
Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice
621
Oral versus intravenous acetaminophen as a constituent of multimodal analgesia after coronary artery bypass graft surgery: A randomized, blinded trial
622
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
623
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
624
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
625
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
626
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
627
Oral Versus Intravenous Rehydration of Moderately Dehydrated Children: A Randomized, Controlled Trial
628
ORAL VERSUS NASAL VASOPRESSIN IN THE TREATMENT OF NOCTURNAL ENURESIS IN 5- TO 12-YEAR-OLD CHILDREN
629
Oral versus Parenteral Iron Therapy for correction of Iron Deficiency Anaemia in Pregnancy
630
Oral versus rectal route of misoprostol administration: a randomized controlled trial
631
Oral versus vaginal misoprostol for induction of labor: A double-blind randomized controlled trial
632
Oral Versus Vaginal Misoprostol for Induction of Labour
633
Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results
634
Oral viral infections
635
Oral vitamin b12 therapy in vitamin b12 deficiency
636
Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation
637
Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect
638
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
639
Oral vitamin K prophylaxis for newborn infants: safe enough?
640
Oral Vocabulary as a Predictor of English Language Proficiency among Malaysian Chinese Preschool Children
641
Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: A prospective randomized clinical trial: Mombelli G, Pezzoli R, Pinoja-Lutz G, et al Arch Intern Med 159:53–58 January
642
Oral Wheat Immunotherapy in a Patient with Anaphylaxis Despite Negative Sensitization Tests
643
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
644
Oral Yeast Colonization and Fungal Infections in Peritoneal Dialysis Patients: A Pilot Study
645
Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
646
Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial
647
ORAL ZINC SULPHATE VS. TOPICAL APPLICATION OF SALICYLIC (16.7%) LACTIC ACID (16.7%) COMBINATION IN THE TREATMENT OF PLANTAR WARTS
648
Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy
649
Oral Zinc Supplementation Positively Affects Linear Growth, But not Weight, in Children 6‑24 Months of Age
650
Oral, gastric and intestinal influences on the control of appetite and feeding in humans
651
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature
652
OralCard: A bioinformatic tool for the study of oral proteome
653
Oral-contraceptive use and risk of hip fracture: a case-control study
654
ORAL-DENTAL HEALTH PROTOCOLS IN PEDIATRIC INTENSIVE CARE UNITS
655
Oral-facial-digital syndrome type II: Transitional type between Mohr and Varadi
656
Oral-facial-digital syndrome type VI with self mutilations
657
Oral-facial-digital syndrome with mesoaxial polysyndactyly,common AV canal,hirschsprung disease and sacral dysgenesis: Probably a transitional type between II,VI,variant of type VI or a new type
658
Oral-health status of inpatients with schizophrenia in Taiwan
659
Orality and literacy in public discourse: An interview of Hannah Arendt
660
Orality and the Sermonic Tradition in J. California Cooperʹʹs Some People, Some Other Place- A Study of the Narrative Voice
661
Orality in the library: How mobile phones challenge our understandings of collaboration in hybridized information centers Original Research Article
662
Orality to literacy: effects on nursing knowledge
663
Orality, Storytelling the Metafictional Space of Narration in Stephen Crane’s The Red Badge of Courage
664
Orall -arginine improves endothelial dysfunction in patients with essential hypertension
665
Oral-Language Skills of the Iranian Pupils With Hearing-Impairment
666
Orally active 1,2,4-trioxepanes: Synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice Original Research Article
667
Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2
668
Orally active amino functionalized antimalarial 1,2,4-trioxanes
669
Orally active antimalarials: Synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice
670
Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors
671
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety Original Research Article
672
Orally active cephalosporins. Part 2: Synthesis, structure–activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain Original Research Article
673
Orally active cephalosporins. Part 3: synthesis, structure–activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins Original Research Article
674
Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains Original Research Article
675
Orally active cephalosporins: synthesis, structure–activity relationships and oral absorption of 3-[(E) and (Z)-2-Substituted vinyl]-cephalosporins Original Research Article
676
Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues
677
Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice
678
Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives Original Research Article
679
Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives
680
Orally active factor Xa inhibitors: Investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy
681
Orally active indole N-oxide PDE4 inhibitors
682
Orally active inhibitors of stromelysin-1 (MMP-3)
683
Orally active insulin mimics: where do we stand now?
684
Orally active iron chelators
685
Orally active PDE4 inhibitors with therapeutic potential
686
Orally active prostacyclin analogue in primary pulmonary hypertension
687
Orally active thrombin inhibitors. Part 1: Optimization of the P1-moiety
688
Orally active thrombin inhibitors. Part 2: Optimization of the P2-moiety
689
Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice
690
Orally administered heparin for preventing deep venous thrombosis
691
Orally administered LPS enhances head kidney macrophage activation with down-regulation of IL-6 in common carp (Cyprinus carpio)
692
Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery
693
Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery
694
Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause
695
Orally available cidofovir derivative active against smallpox
696
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus
697
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
698
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model
699
Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase
700
Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K
701
Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity
702
Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability
703
Orally Disintegrating Tablets: A Review
704
Orally Efficacious NR2B-Selective NMDA Receptor Antagonists
705
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif
706
Orally provoked urinary nickel excretion during disulfiram treatment
707
Oralmucoadhesive paste of Triamcinolone Acetonide and Zinc Sulfate: Preparation and in vitro physicochemical characterization
708
Oral-Periodontal Health and Cytokine Storm: Correlation and Preventive Measures
709
Oral-to-inhalation route extrapolation in occupational health risk assessment: a critical assessment
710
Orang Asli (aboriginal) community participation in the tourism industry - A preliminary survey of Belum-Temenggor
711
Orang Asli Talks in Akiya’s Tuntut
712
Orang Kulisusu. Identitas dan Kekuasaan Reproduksi Identitas Kultural dalam Proses Pemekaran Kabupaten Buton Utara
713
Orang Pekak Sebagai Cacat Atau Pengguna Minoriti Bahasa: Perspektif Perubatan Dan Linguistik
714
Orang Suku Laut dan Orang Melayu di Kepulauan Riau: Sebuah Tafsir Deskriptif-Etnografis
715
Orange (Citrus sinensis) juice concentration by reverse osmosis Original Research Article
716
Orange and green monkeys jumping around the room
717
Orange and red organic light-emitting devices using aluminum tris(5-hydroxyquinoxaline)
718
Orange and Sunlight: A Recipe for Blisters
719
Orange emission enhancement by energy transfer in Sr3Al2O5Cl2:Ce3+, Eu2+ phosphor for solid-state lighting
720
Orange emissive phosphor for warm-white light-emitting diodes
721
Orange G and Remazol Brilliant Blue R decolorization by white rot fungi Dichomitus squalens, Ischnoderma resinosum and Pleurotus calyptratus
722
Orange Harvesting Systems Review Review Article
723
Orange Hot’ Anthurium
724
Orange II adsorption on palygorskites modified with alkyl trimethylammonium and dialkyl dimethylammonium bromide — An isothermal and kinetic study
725
Orange II photocatalysis on immobilised TiO2: Effect of the pH and H2O2
726
Orange is good for health of hunters
727
Orange juice concentration by osmotic evaporation and membrane distillation: A comparative study Original Research Article
728
Orange juice—anticancer activity
729
Orange juice—anticancer activity
730
Orange Luminescence and Structural Properties of Three Isostructural Halocyclohexylisonitrilegold(I) Complexes
731
Orange oil stability in spray dry delivery systems
732
Orange peel as an adsorbent in the removal of Acid violet 17 (acid dye) from aqueous solutions
733
Orange Peel Essential Oil as Component of a Metal Sensor for Lead (II) Ion Determination in Aqueous Solutions
734
Orange peel pretreatment in a novel lab-scale direct steam-injection apparatus for ethanol production
735
Orange pulp improves antioxidant status and suppresses lipid peroxidation in orchidectomized male rats
736
Orange tree simulation under heterogeneous environment using agent-based model ORASIM
737
Orange-spotted grouper (Epinephelus coioides) TLR2, MyD88 and IL-1β involved in anti-Cryptocaryon irritans response
738
Orange-spotted grouper (Epinephelus coioides) toll-like receptor 22: Molecular characterization, expression pattern and pertinent signaling pathways
739
Orangutan population density, forest structure and fruit availability in hand-logged and unlogged peat swamp forests in West Kalimantan, Indonesia Original Research Article
740
Orang-utans rely on orientation cues and egocentric rules when judging othersʹ perspectives in a competitive food task
741
ORASSYLL: Object Recognition with Autonomously Learned and Sparse Symbolic Representations Based on Metrically Organized Local Line Detectors
742
ORASSYLL: Object Recognition with Autonomously Learned and Sparse Symbolic Representations Based on Metrically Organized Local Line Detectors
743
Oravec, Jo Ann, Virtual individuals, virtual groups : New York: Cambridge University Press, 1996. 389 pp. $49.95. ISBN: 0-521-45493-X
744
Orbiculari myectomy with levator advancement in chwartz-jampel yndrome
745
Orbicularis Oculi Myectomy as a Treatment for Blepharospasm in a Case of Schwartz Jampel Syndrome
746
Orbicularis oculi myocutaneous flap in reconstruction of postburn lower eyelid ectropion
747
Orbifold analysis of broken bulk symmetries
748
Orbifold and orientifold compactifications of F-theory and M-theory to six and four dimensions Original Research Article
749
Orbifold breaking of 3–3–1 model
750
Orbifold breaking of left–right gauge symmetry
751
Orbifold duality symmetries and quantum Hall systems Original Research Article
752
Orbifold genera, product formulas and power operations
753
Orbifold index cobordism invariance
754
Orbifold matrix model Original Research Article
755
Orbifold physics and de Sitter spacetime Original Research Article
756
Orbifold projection in supersymmetric QCD at Nf⩽Nc
757
Orbifold resolution by D-branes Original Research Article
758
Orbifold symmetry reductions of massive boson–fermion degeneracy Original Research Article
759
Orbifold Zhu theory associated to intertwining operators
760
Orbifolded SU(7) and unification of families
761
Orbifold-induced μ term and electroweak symmetry breaking
762
Orbifolding the twistor string Original Research Article
763
Orbifolds and groupoids
764
Orbifolds and solitons
765
Orbifolds of AdS5 × S5 and 4d conformal field theories Original Research Article
766
Orbifolds of AdS7×S4 and six dimensional (0,1) SCFT
767
Orbifolds of M-theory and type II string theories in two dimensions Original Research Article
768
Orbifolds of M-theory Original Research Article
769
Orbifolds with discrete torsion and mirror symmetry
770
ORBIT – operating-regime-based modeling and identification toolkit
771
Orbit analysis of the satellite westpac Original Research Article
772
Orbit and Attitude Control of a GEO Satellite in Station Keeping Flight Mode
773
Orbit and bulk density of the OSIRIS-REx target Asteroid (101955) Bennu
774
Orbit and emission spectroscopy of α-Capricornid fireballs
775
Orbit bump by DC magnets and halo collimation for the RCS extraction
776
Orbit bump by DC magnets and halo collimation for the RCS extraction
777
Orbit closure diagram for the space of quadruples of quinary alternating forms
778
Orbit compensation for the time-varying elliptically polarized wiggler operating at 100 Hz
779
Orbit compensation for the time-varying elliptically polarized wiggler operating at 100 Hz
780
Orbit computation for transneptunian objects
781
Orbit correction in an orbit separated cyclotron
782
Orbit correction in an orbit separated cyclotron
783
Orbit correction using an eigenvector method with constraints for synchrotron radiation sources
784
Orbit correction using an eigenvector method with constraints for synchrotron radiation sources
785
Orbit decomposition of subset actions
786
Orbit design for launching INTEGRAL on the Proton/Block-DM launcher
787
Orbit determination and errors of a star catalogue
788
Orbit determination for the GOCE satellite Original Research Article
789
Orbit determination in satellite geodesy Original Research Article
790
Orbit determination of satellite “Tance 1” with VLBI data
791
Orbit determination performances using single- and double-differenced methods: SAC-C and KOMPSAT-2 Original Research Article
792
Orbit determination with very short arcs: II. Identifications
793
Orbit distribution on 2 under the natural action of SL(2, )
794
Orbit entropy versus the symmetry index
795
Orbit equivalence and von Neumann algebras for expansive interval maps
796
Orbit feedback at the NSLS
797
Orbit feedback at the NSLS
798
Orbit improvement for GEO objects using follow-up observations Original Research Article
799
Orbit improvement for GTO objects using follow-up observations Original Research Article
800
Orbit Lengths and Character Degrees in p-Sylow Subgroups of Some Classical Lie Groups Original Research Article
801
Orbit Lengths and Character Degrees in p-Sylow Subgroups of Some Classical Lie Groups Original Research Article
802
Orbit maintenance of a lunar polar orbiter
803
Orbit of an image under iterated system
804
Orbit of Comet C/1845 D1 (de Vico) and the utility of Bulirsch–Stoer integration
805
Orbit of Comet C/1854 L1 (Klinkerfues)
806
Orbit of the Great Comet of 1854 (C/1854 F1)
807
Orbit perturbations in the vicinity of an active cometary nucleus
808
Orbit sizes, character degrees and Sylow subgroups
809
Orbit spaces and unions of equivariant absolute neighborhood extensors
810
Orbit spaces of proper equivariant absolute extensors
811
Orbit spaces of proper equivariant absolute extensors
812
Orbit spaces of proper equivariant absolute extensors
813
Orbital abscess after extraction of a maxillary wisdom tooth
814
Orbital adenocarcinoma of lacrimal gland origin in a dog
815
Orbital alveolar echinococcosis: A case report
816
Orbital alveolar soft part sarcoma: Histopathologic report of two cases
817
Orbital analysis of TTF molecules adsorbed on the Au surface
818
Orbital analysis of TTF molecules adsorbed on the Au surface
819
Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy
820
Orbital and charge orderings and magnetism in perovskite-type transition-metal oxides
821
Orbital and Field Angular Momentum in the Nucleon
822
Orbital- and millennial-scale changes of radiolarian assemblages during the last 220 kyrs in the Japan Sea
823
Orbital and millennial-scale environmental and sedimentological changes in the Okhotsk Sea during the last 350 kyr
824
Orbital- and millennial-scale variations in Asian dust transport path to the Japan Sea
825
Orbital and millennium scale environmental changes in the southern Bering Sea during the last glacial-Holocene: Geochemical and paleontological evidence
826
Orbital and mission planning constraints for the deflection of NEOs impacting on Earth
827
Orbital and Preseptal Cellulitis: Epidemiology, Etiology, and Management
828
Orbital and spin effects in the low-temperature behavior of the magnetoresistance of doped CdTe crystals
829
Orbital and spin motion in a storage ring with static electric and magnetic fields
830
Orbital and spin motion in a storage ring with static electric and magnetic fields
831
Orbital and strongly orbital spaces
832
Orbital and suborbital environmental changes in the southern Bering Sea during the last 50 kyr
833
Orbital and suborbital variability in North Atlantic bottom water temperature obtained from deep-sea ostracod Mg/Ca ratios
834
Orbital and thermal evolutions of four potential targets for a sample return space mission to a primitive near-Earth asteroid
835
Orbital and ventromedial prefrontal cortex functioning in Parkinson’s disease: Neuropsychological evidence
836
Orbital Angioleiomyoma: Report of a Case
837
ORBITAL ANGULAR MOMENTUM DENSITY OF AN ELEGANT LAGUERRE-GAUSSIAN BEAM
838
Orbital angular momentum in phase space Original Research Article
839
Orbital anisotropy in SnO2 thin films and its modification by swift heavy ion irradiation
840
Orbital apex injury: trauma at the junction between the face and the cranium
841
Orbital apex syndrome caused by sphenoethmoid mucocele
842
Orbital approximation for the reduced Bloch equations: Fermi–Dirac distribution for interacting fermions and Hartree–Fock equation at finite temperature
843
Orbital based electronic structural signatures of the guanine keto G-7H/G-9H tautomer pair as studied using dual space analysis Original Research Article
844
Orbital celluliti caued by Fuobacterium necrophorum
845
Orbital Celluliti in a Patient Receiving Infliximab for Ankyloing pondyliti
846
Orbital celluliti, panophthalmiti, and ecthyma gangrenoum in an immunocompromied hot with peudomona epticemia
847
Orbital Cellulitis Due To Leech Therapy
848
Orbital Cellulitis Following Uncomplicated Glaucoma Drainage Device Surgery: Case Report and Review of Literature
849
Orbital cellulitis in a burned child
850
Orbital Cellulitis Secondary to Dacryocystitis: A Case Report
851
Orbital change experiments with a Mars general circulation model
852
Orbital chondroarcoma developing in a patient with Paget dieae
853
Orbital chronology of Early Eocene hyperthermals from the Contessa Road section, central Italy
854
Orbital clustering of martian Trojans: An asteroid family in the inner Solar System?
855
Orbital compartment syndrome resulting in unilateral blindness in two dogs
856
Orbital compartment yndrome caued by intraorbital bacitracin ointment after endocopic inu urgery
857
Orbital Complications of Sinusitis
858
Orbital compreion yndrome after orbital extravaation of X-ray contrat material
859
Orbital control of π-facial selectivity in Diels–Alder reactions of cyclopentadienes having C(O)YR substituents at the 5-positions
860
Orbital control on Upper Triassic Playa cycles of the Steinmergel-Keuper (Norian): A new concept for ancient playa cycles
861
Orbital currents and charge density waves in a generalized Hubbard ladder
862
Orbital currents in underdoped cuprates Original Research Article
863
Orbital cycles in a Late Cretaceous shallow platform (Iberian Ranges, Spain)
864
Orbital cyclicity in the Eocene of Angola: visual and image-time-series analysis compared
865
Orbital cyclostratigraphy of the Devonian Frasnian–Famennian transition in South China
866
Orbital cysticercosis: A case report
867
Orbital cyticercoi-aociated cleral indentation preenting with peudo–retinal detachment
868
Orbital debris impact simulation using a parallel hybrid particle-element code
869
Orbital debris–debris collision avoidance Original Research Article
870
Orbital Desmoid-Type Fibromatosis: A Case Report andLiterature Review
871
Orbital Dieae—Preent tatu and Future Challenge
872
Orbital dispersion and Earth-impact probability analysis for fragmented asteroids
873
Orbital Doppler Evaluation of Blood Flow Velocities in Optic Neuritis
874
Orbital dynamics in a storage ring with electrostatic bending
875
Orbital dynamics in a storage ring with electrostatic bending
876
Orbital dynamics of the CuXn complex in solids
877
Orbital dynamics, environmental heterogeneity, and the evolution of the human brain
878
Orbital effect of a magnetic field on two-leg Hubbard ladder
879
Orbital effects on Mercury’s escaping sodium exosphere
880
Orbital electrode actuation to improve efficiency of drilling micro-holes by micro-EDM
881
Orbital elements discretization method to calculate spatial density and flux Original Research Article
882
Orbital Emphysema due to Nose Blowing
883
Orbital Emphysema in an 8-Year-Old Patient Caused by Air Injury
884
Orbital evolution and accretion of protoplanets tidally interacting with a gas disk: I. Effects of interaction with planetesimals and other protoplanets
885
Orbital evolution and accretion of protoplanets tidally interacting with a gas disk: II. Solid surface density evolution with type-I migration
886
Orbital Evolution of Impact Ejecta from Ganymede
887
Orbital evolution of small binary asteroids
888
Orbital evolution of space debris Original Research Article
889
Orbital evolution of the Gefion and Adeona asteroid families: close encounters with massive asteroids and the Yarkovsky effect
890
Orbital evolution of two near-earth asteroids: Nereus and 1989 ML Original Research Article
891
Orbital evolution studies of two HMXB pulsars Original Research Article
892
Orbital exenteration: One ize doe not fit all
893
Orbital expansion and resonant trapping during the late accretion stages of the outer planets
894
Orbital Extension of a Giant Ethmoidal Sinus Osteoma in a 30-Year-old Female
895
Orbital Fano–Kondo effect in double quantum dots
896
Orbital floor implant migration acro the ethmoidal inue and naal eptum
897
Orbital fluctuation theory in iron-based superconductors: -wave superconductivity, structure transition, and impurity-induced nematic order
898
Orbital fluctuations and orbital order in FeCr2S4 Original Research Article
899
Orbital forcing and cyclic sequences : Edited by P. L. de Boer and D. G. Smith Special Publication of the International Association of Sedimentologists; Blackwell Scientific Publications 1994; ISBN 0632037369
900
Orbital forcing and Eocene continental temperatures
901
Orbital forcing as principal driver for fine-grained deep-marine siliciclastic sedimentation, Middle-Eocene Ainsa Basin, Spanish Pyrenees
902
Orbital forcing in a ‘Boreal’ Cretaceous epeiric sea: high-resolution analysis of core and logging data (Upper Albian of the Kirchrode I drill core — Lower Saxony basin, NW Germany)
903
Orbital forcing in Pliocene–Pleistocene Mediterranean lacustrine deposits: dominant expression of eccentricity versus precession
904
Orbital forcing of freshwater input in the Zaire Fan area—clay mineral evidence from the last 200 kyr
905
Orbital forcing of organic carbon burial in the proto-North Atlantic during oceanic anoxic event 2
906
Orbital formal normal forms for general Bogdanov–Takens singularity
907
Orbital forming of tailored blanks from sheet metal
908
Orbital Fracture: Significance of lateral wall
909
Orbital fractures. Diagnosis, operative treatment, secondary corrections
910
Orbital fractures: ophthalmic or maxillofacial?
911
Orbital frequencies in radiolarian assemblages of the central Indian Ocean: implications on the Indian summer monsoon
912
Orbital ganglioglioma ariing from ectopic neural tiue
913
Orbital Graphs for the Small Residue Class of PSL(2, 5)
914
Orbital HP-Clouds for solving Schrödinger equation in quantum mechanics Original Research Article
915
Orbital Hydatid Cyst with Diverse Locality in the Orbit and Review of Literatures
916
Orbital identification of clays and carbonates in Gusev crater
917
Orbital imaging and assessment of different orbital models for the valence shell of methanol: Comparison of electron momentum spectroscopy measurements with near-Hartree–Fock limit, MRSD-CI, localized valence bond and density functional theory Original Re
918
Orbital imaging for the valence shell of sulphur dioxide: comparison of EMS measurements with near Hartree–Fock limit and density functional theory Original Research Article
919
Orbital Infarction in ickle Cell Dieae Original Reearch Article
920
Orbital inferences from GFO with applications to GEOSAT Original Research Article
921
Orbital insolation forcing of the Indian Monsoon – a motor for global climate changes?
922
Orbital instability and prediction of a Bunsen flame tip motion with burner rotation
923
Orbital Integrals on Symmetric Spaces and Spherical Characters Original Research Article
924
Orbital Integrals on Symmetric Spaces and Spherical Characters Original Research Article
925
Orbital interaction and local stability of Ni substituted Pd nanoalloys
926
Orbital invasion of ameloblastoma: A systematic review apropos of a rare entity
927
Orbital linearization around equilibria of vector fields in and Lie symmetries
928
Orbital linkages of Comet 6P/dʹArrest based on its asymmetric light curve
929
Orbital Lymphangioma: A Case Report and Review of Management Modalities
930
Orbital Magnetism in Confined Two Dimensional Systems
931
Orbital maneuvers using gravitational capture times Original Research Article
932
Orbital mapping of carbon thin films by XANESspectromicroscopy
933
Orbital mapping of carbon thin films by XANES-spectromicroscopy
934
Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies
935
Orbital Metastasis from Breast Cancer Without Significant Changes in CT Scan and MRI
936
Orbital Metastasis from Rectal Adenocarcinoma- Report of a Rare Case
937
Orbital Metastasis of Hepatocellular Carcinoma: A Case Report
938
Orbital Metastasis: A Rare Manifestation of Scapular Bone Osteosarcoma
939
Orbital Metastatic Osteosarcoma
940
Orbital Migration and Mass Accretion of Protoplanets in Three-dimensional Global Computations with Nested Grids
941
Orbital mixing in CO chemisorption on transition metal surfaces
942
Orbital mixing in solids as a descriptor for materials mapping
943
Orbital moment determination of simple transition metal oxides using magnetic X-ray diffraction Original Research Article
944
Orbital moments of 3d adatoms and Co nanostructures on Cu(0 0 1) surfaces
945
Orbital moments of CrO2 and Fe3O4 studied by MCD in soft X-ray absorption
946
Orbital momentum profiles and binding energy spectra for the complete valence shell of molecular fluorine Original Research Article
947
Orbital motion in generalized static fields of FELs accounting for axial magnetic field, beam forces, undulator and external focusing
948
Orbital motion in generalized static fields of FELs accounting for axial magnetic field, beam forces, undulator and external focusing
949
Orbital motion of the massive multiple stars in the Orion Trapezium
950
Orbital mucormycosis in an immunocompetent individual
951
Orbital Myeloid Sarcoma in Acute Myeloid Leukemia: A Case Report
952
Orbital Myiasis
953
Orbital observations of meteors in the Martian atmosphere using the SPOSH camera
954
Orbital Oculomotor Nerve Schwannoma Extending to the Cavernous Sinus: A Rare Cause of Proptosis
955
Orbital order in NaTiO2: A first principles study
956
Orbital order–disorder transition in La1−xBaxMnO3 in the low-doping region
957
Orbital ordering in Mott-insulators La2O3Fe2Se2 and La2O3Co2Se2
958
Orbital ordering induced ferromagnetism in Lu2V2O7
959
Orbital orderings and excitations in ferromagnetic metallic manganites Original Research Article
960
Orbital orientation is not visual orientation: A comment on “X-ray Vision and the evolution of forward-facing eyes” by M.A. Changizi and S. Shimojo
961
Orbital origin and matrix element effects in the Ag/Si(1 1 1)-()R30° Fermi surface
962
Orbital performance of AMPTE/CCE nickel-cadmium batteries with a large number of charger-induced, very small, charge/discharge cycles
963
Orbital period investigations of two short-period early-type overcontact binaries BH Cen and V701 Sco in two extremely young galactic clusters IC 2944 and NGC 6383
964
Orbital period study of the Algol-type eclipsing binary system
965
Orbital phase control of conformations of alkyne derivatives
966
Orbital phase in Suzuki–Miyaura cross-coupling reactions
967
Orbital phase spectroscopy of four high mass X-ray binary pulsars to study the stellar wind of the companion Original Research Article
968
Orbital phase spectroscopy of X-ray pulsars to study the stellar wind of the companion Original Research Article
969
Orbital polarization of LaSrMnO4 studied by soft X-ray linear dichroism
970
Orbital propagation for Brazilian satellites using NORAD models Original Research Article
971
Orbital properties of Jupiter-family comets
972
Orbital Radar Studies of Paleodrainages in the Central Namib Desert
973
Orbital radiologic parameters of non-syndromic exorbitism patients in comparison with normal population
974
Orbital Radiotherapy Plus Concomitant Steroids in Moderate-to-Severe Graves’ Ophthalmopathy: Good Results After Long-Term Follow-Up
975
Orbital reconstruction following sino-nasal mucormycosis
976
Orbital resonances in the inner neptunian system: I. The 2:1 Proteus–Larissa mean-motion resonance
977
Orbital resonances in the inner neptunian system: II. Resonant history of Proteus, Larissa, Galatea, and Despina
978
Orbital retinoblastoma: Present status and future challenges – A review
979
Orbital rhabdomyosarcomas: A review
980
Orbital Rosai–Dorfman Disease in a fifty-eight years old woman
981
Orbital Schemes ofB3(q) Acting on 2-Dimensional Totally Isotropic Subspaces
982
Orbital simulation life tests of nickel hydrogen batteries with additional non-eclipse cycles
983
Orbital solitary fibrous tumor: A rare clinicopathologic correlation and review of literature - A Solitary fibrous tumor in the orbit
984
Orbital stability of bound states of nonlinear Schrödinger equations with linear and nonlinear optical lattices
985
Orbital stability of Earth-type planets in stellar binary systems
986
Orbital stability of negative solitary waves Original Research Article
987
Orbital stability of peakons for the Degasperis–Procesi equation with strong dispersion Original Research Article
988
ORBITAL STABILITY OF PROTOPLANETARY SYSTEMS IN NEBULAR GAS AND IMPLICATIONS FOR TERRESTRIAL PLANET FORMATION
989
Orbital Stability of Solitary Wave Solutions for an Interaction Equation of Short and Long Dispersive Waves
990
Orbital stability of solitary waves for a shallow water equation
991
Orbital stability of solitary waves for Kundu equation
992
Orbital Stability of Solitary Waves for the Nonlinear Derivative Schrödinger Equation
993
Orbital stability of solitary waves of the long wave-short wave resonance equations
994
Orbital stability of standing waves for semilinear wave equations with indefinite energy
995
Orbital stability of standing waves of two-component Bose–Einstein condensates with internal atomic Josephson junction
996
Orbital stability of systems of closely-spaced planets
997
Orbital states and polarized X-ray absorption
998
Orbital Structure Analysis in Molecular Electronics
999
Orbital subperiosteal abscess and blindness complicating a minimally displaced zygomatic complex fracture
1000
Orbital Symmetric Spaces and Finite Multiplicity